In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
GHTC members the Global Alliance for TB Drug Development and the Foundation for Innovative New Diagnostics have announced a partnership that aims to coordinate the development of complementary new tools to fight tuberculosis (TB). In related news, GHTC member Aeras has released its annual report and a new infographic about the global burden of TB and the need to develop new products to control the disease.
The Global Alliance to Prevent Prematurity and Stillbirth has announced five innovative research projects that aim to prevent premature birth worldwide. The initiative seeks to discover biological mechanisms that lead to preterm birth and develop innovative strategies for prevention, with particular focus on solutions relevant to low- and middle-income countries.
A new study defines factors that can lead to successful open-source drug discovery for neglected diseases.
GHTC member Research!America has released a list that details the top 10 reasons the United States should invest in global health research and development.